← Open Payments lookup

GABRIEL DIAZ: Open Payments

NPI 1124492798 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,029 in 102 payments from 17 companies in 2025. Trend: 2023 $2,992 · 2024 $3,231 · 2025 $4,029

Food & beverage: $3,945Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.24$1,157
ABBVIE INC.22$576
Janssen Scientific Affairs, LLC4$449
GENZYME CORPORATION8$315
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$307
PFIZER INC.8$291
Takeda Pharmaceuticals U.S.A., Inc.7$208
Phathom Pharmaceuticals, Inc.6$193
Alexion Pharmaceuticals, Inc.1$126
Madrigal Pharmaceuticals3$92

Products named: TREMFYA, DUPIXENT, XIFAXAN, ENTYVIO, CREON, VOQUEZNA, VELSIPITY, RINVOQ.

Industry payments across DC — which companies pay providers there.